Well, it is that time of year again. I am taking my usual two-month break from blogging, a.k.a, a blogcation. Yes, I'm sorry to report that your subscription fees only covers 10 months of Drug Channels.
Drug Channels is now read by almost 5,000 people each month (and gets almost 12,000 unique visits monthly). Obviously, I only know only a small fraction of you. If you haven't done so, please send me a message if you'd like to chat on the phone or even meet in person at the NACDS meeting in August. (I'll be working during most of July and August despite the blog's summer hiatus.) I'd be pleased to discuss how I help people understand this evolving industry and develop strategies to deal with it. Plus, meeting me in person at NACDS may convince you that I am not just a computer generated avatar.
My summer reading list from 2008 is still worthwhile if you are looking for something wonky to bring to the beach. See Summer Reading. If those books are not enticing enough, you can always revisit some of the most popular and controversial Drug Channels posts from 2009 (in chronological order):
- Who Will Pay for Prescription Drugs?
- Drug Channel Profits in 2009's Fortune 500 list
- Is Walgreens planning a direct-to-payer deal?
- Wal-Mart Aims at PBM Mail Profits
- Reality Check on Mail Economics
- The Odd Economics of Maintenance Choice
- Profit Headwinds for Cardinal Health
- PBM Consolidation Ahead
- 2008 Pharmacy Market Share Data
I'll be back to blogging after Labor Day. Have a great summer!